ATE308616T1 - Rantes mutanten und deren therapeutische verwendungen - Google Patents

Rantes mutanten und deren therapeutische verwendungen

Info

Publication number
ATE308616T1
ATE308616T1 AT98966650T AT98966650T ATE308616T1 AT E308616 T1 ATE308616 T1 AT E308616T1 AT 98966650 T AT98966650 T AT 98966650T AT 98966650 T AT98966650 T AT 98966650T AT E308616 T1 ATE308616 T1 AT E308616T1
Authority
AT
Austria
Prior art keywords
rantes
therapeutic uses
rantes mutants
mutants
wild
Prior art date
Application number
AT98966650T
Other languages
English (en)
Inventor
Paolo Lusso
Simona Polo
Original Assignee
San Raffaele Centro Fond
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI972865 external-priority patent/IT1297015B1/it
Priority claimed from IT98MI001866 external-priority patent/IT1302012B1/it
Application filed by San Raffaele Centro Fond filed Critical San Raffaele Centro Fond
Application granted granted Critical
Publication of ATE308616T1 publication Critical patent/ATE308616T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98966650T 1997-12-23 1998-12-21 Rantes mutanten und deren therapeutische verwendungen ATE308616T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI972865 IT1297015B1 (it) 1997-12-23 1997-12-23 Mutanti di rantes e loro applicazioni terapeutiche
IT98MI001866 IT1302012B1 (it) 1998-08-07 1998-08-07 Derivati di rantes e loro applicazioni terapeutiche.
PCT/EP1998/008354 WO1999033989A2 (en) 1997-12-23 1998-12-21 Rantes mutants and therapeutic applications thereof

Publications (1)

Publication Number Publication Date
ATE308616T1 true ATE308616T1 (de) 2005-11-15

Family

ID=26331556

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03027936T ATE308617T1 (de) 1997-12-23 1998-12-21 Rantes mutanten und deren therapeutischen anwendungen
AT98966650T ATE308616T1 (de) 1997-12-23 1998-12-21 Rantes mutanten und deren therapeutische verwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03027936T ATE308617T1 (de) 1997-12-23 1998-12-21 Rantes mutanten und deren therapeutischen anwendungen

Country Status (10)

Country Link
US (2) US6608177B1 (de)
EP (2) EP1040191B1 (de)
JP (1) JP4323094B2 (de)
AT (2) ATE308617T1 (de)
AU (1) AU2415599A (de)
CA (1) CA2316447C (de)
DE (2) DE69832216T2 (de)
DK (2) DK1431391T3 (de)
ES (2) ES2247738T3 (de)
WO (1) WO1999033989A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
US7175988B2 (en) 2001-02-09 2007-02-13 Human Genome Sciences, Inc. Human G-protein Chemokine Receptor (CCR5) HDGNR10
CA2468790A1 (en) 2001-12-17 2003-06-26 Applied Research Systems Ars Holding N.V. Chemokine mutants acting as chemokine antagonists
US7393934B2 (en) 2001-12-21 2008-07-01 Human Genome Sciences, Inc. Human G-protein chemokine receptor (CCR5) HDGNR10
AU2003240758B2 (en) * 2002-04-04 2008-03-13 Laboratoires Serono Sa Chemokines mutants having improved oral bioavailability
CA2559809A1 (en) 2004-03-12 2005-11-10 Human Genome Sciences, Inc. Antibodies against human g-protein chemokine receptor (ccr5) hdgnr10
EP2091971A4 (de) * 2006-11-13 2010-05-05 Functional Genetics Inc Therapeutisches targeting von escort-proteinen
WO2009054873A2 (en) * 2007-08-02 2009-04-30 Novimmune S.A. Anti-rantes antibodies and methods of use thereof
CN112469430B (zh) 2018-05-28 2024-12-24 日内瓦大学 抑制大脑炎症的方法
WO2025172252A1 (en) * 2024-02-15 2025-08-21 Novo Nordisk A/S Protracted ccr5 antagonists and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221089B1 (en) * 1994-12-08 2002-08-28 Glaxo Group Ltd Rantes peptide derivates with antagonistic effect and uses thereof
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
AU4561497A (en) * 1996-09-25 1998-04-17 British Biotech Pharmaceuticals Limited Human rantes mutants incapable of aggregate formation

Also Published As

Publication number Publication date
DE69832216T2 (de) 2006-05-24
EP1040191A2 (de) 2000-10-04
US6608177B1 (en) 2003-08-19
DE69832216D1 (de) 2005-12-08
US20030216549A1 (en) 2003-11-20
EP1431391B1 (de) 2005-11-02
DE69832197T2 (de) 2006-05-24
EP1040191B1 (de) 2005-11-02
CA2316447C (en) 2009-07-28
WO1999033989A2 (en) 1999-07-08
EP1431391A3 (de) 2004-10-06
ES2247738T3 (es) 2006-03-01
JP2002507388A (ja) 2002-03-12
DK1431391T3 (da) 2005-12-19
WO1999033989A3 (en) 1999-08-26
US7164000B2 (en) 2007-01-16
DE69832197D1 (de) 2005-12-08
JP4323094B2 (ja) 2009-09-02
AU2415599A (en) 1999-07-19
CA2316447A1 (en) 1999-07-08
DK1040191T3 (da) 2005-12-19
EP1431391A2 (de) 2004-06-23
ATE308617T1 (de) 2005-11-15
ES2247475T3 (es) 2006-03-01

Similar Documents

Publication Publication Date Title
ATE185602T1 (de) Verändertes menschliches il-6
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
NO911624L (no) Farmasoeytiske forbindelser.
PH31441A (en) 5.Substituted derivatives of mycophenolic acid.
ATE308616T1 (de) Rantes mutanten und deren therapeutische verwendungen
DE69033703D1 (de) Nichtglykosyliertes fgf-4 und dieses enthaltende präparate
ES2177625T3 (es) Citoquina cc-1 humana circulante.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
ATE186731T1 (de) Anomere fluorribosylamine
FR2710244B3 (fr) Composition diététique à base d'acides aminés essentiels.
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IT8840172A0 (it) Procedimento e mezzi per l'impressione in rilievo di tessuti, o pelli e simili
Dozeman The Life of Moses: The Yahwist as Historian in Exodus-Numbers
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
IT8722543V0 (it) Cerotto, in particolare per l'impiego in corrispondenza di zone articolari.
DE3689850D1 (de) Peptide und deren Verwendung in der Therapie.
Palani Professor Dr. N. Subbu Reddiar's contributions for the enrichment of Tamil
IT1230707B (it) Pirimidine 2 4 disostituite loro preparazione ed impieghi terapeutici.
ITRM920079A1 (it) Manufatto per l'allargamento di banchine stradali e procedimento di posa in opera.
ITRM930343A0 (it) Proteine ricombinanti, vettori per l'espressione e loro usi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1040191

Country of ref document: EP